Messenger RNA therapeutics company, moderna (MRNA), if successful, could completely transform modern medicine. We're talking a potential paradigm-shift here. They're using messenger RNA (mRNA) to treat a variety of diseases with their three programs covering immuno-oncology, vaccines for unmet medical needs, and rare diseases. On December 7, 2018 moderna had the largest IPO in biotech history. They sold ~26.3MM shares at ~$23/share, raising ~ $604MM and valuing the company at ~$7.5B. While massively impressive in its scale, the IPO didn’t go so well. Shares tanked by ~19% shortly thereafter, and the current price